Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Keratosis, Actinic 1Hodgkin Disease 1Dermatitis, Contact 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Basal Cell 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

HhAntag691 15sonidegib 5cemiplimab 5Nivolumab 5Aminolevulinic Acid 5daromun 4Specimen Handling 4Radiotherapy 3Magnetic Resonance Spectroscopy 33-ingenyl angelate 3tazarotene 2relatlimab 2Ipilimumab 2IPI-926 2Drug Evaluation 2Celecoxib 2Biopsy 2talimogene laherparepvec 1remetinostat 1gusacitinib 1endonuclease V, phage T4 1X-Rays 1Triamcinolone 1Sutures 1Surgical Procedures, Operative 1Solutions 1Papillomavirus Vaccines 1Opdualag 1Observation 1Niacinamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Basal Cell × Triamcinolone × Clear all
NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed
DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡